Advanced Training in Urologic Oncology
泌尿肿瘤学高级培训
基本信息
- 批准号:9793339
- 负责人:
- 金额:$ 28.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-22 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Urologic cancers impose a significant burden on the health of Americans with 63,000 individuals succumbing
to the malignancies each year. These numbers are expected to rise over the next several decades as the
population ages. At the same time, the pace of innovation and discovery in cancer-oriented translational
science and health services research continues to accelerate. Thus, a well-prepared research-oriented work
force capable of answering important scientific questions is needed. Unfortunately, traditional clinical training in
urologic oncology falls short of this need. The goal of this T32 renewal application is to prepare urology
trainees for academic careers in urologic oncology by providing a comprehensive research training program in
translational laboratory science or health services research. This proposal is a renewal application to educate 2
research trainees per year for 2 years of training. The program is structured around a research project
supervised by an individualized mentorship committee, including both research and methods mentors, an
interactive and informative series of seminars and a required core curriculum that includes specific graduate
level courses that may lead to a Master’s degree. Entrants to the program will choose between a translational
laboratory science or health services research track depending on their interests. The program will ensure that
each trainee: 1) design, implement, analyze and report a research project, 2) obtain formal instruction on
fundamental research methods, 3) gain instruction on either fundamental principles of cancer biology
(translational science track) or essential elements of conducting health services research (health services
track) and 4) acquire requisite professional skills (e.g., grant writing) to support and sustain a research career.
泌尿系统癌症对美国人的健康造成了巨大的负担,有63,000人死于泌尿系统癌症
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRENT K. HOLLENBECK其他文献
BRENT K. HOLLENBECK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRENT K. HOLLENBECK', 18)}}的其他基金
Physician dispensing of oral specialty drugs for advanced prostate cancer and its implications for patients
医生对晚期前列腺癌口服专科药物的配药及其对患者的影响
- 批准号:
10862259 - 财政年份:2023
- 资助金额:
$ 28.5万 - 项目类别:
Physician dispensing of oral specialty drugs for advanced prostate cancer and its implications for patients
医生对晚期前列腺癌口服专科药物的配药及其对患者的影响
- 批准号:
10560826 - 财政年份:2023
- 资助金额:
$ 28.5万 - 项目类别:
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
调整财政激励措施以促进前列腺癌主动监测的合理使用
- 批准号:
10416477 - 财政年份:2022
- 资助金额:
$ 28.5万 - 项目类别:
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
调整财政激励措施以促进前列腺癌主动监测的合理使用
- 批准号:
10592422 - 财政年份:2022
- 资助金额:
$ 28.5万 - 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
- 批准号:
10432116 - 财政年份:2020
- 资助金额:
$ 28.5万 - 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
- 批准号:
10625489 - 财政年份:2020
- 资助金额:
$ 28.5万 - 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
- 批准号:
10862329 - 财政年份:2020
- 资助金额:
$ 28.5万 - 项目类别:
Impact of urologist practice organization and health policy on prostate cancer treatment, overtreatment and spending
泌尿科医生执业组织和卫生政策对前列腺癌治疗、过度治疗和支出的影响
- 批准号:
10224611 - 财政年份:2017
- 资助金额:
$ 28.5万 - 项目类别:
Impact of urologist practice organization and health policy on prostate cancer treatment, overtreatment and spending
泌尿科医生执业组织和卫生政策对前列腺癌治疗、过度治疗和支出的影响
- 批准号:
9750134 - 财政年份:2017
- 资助金额:
$ 28.5万 - 项目类别:
Accountable care organizations and the diffusion of new surgical procedures
负责任的护理组织和新外科手术的传播
- 批准号:
9067196 - 财政年份:2015
- 资助金额:
$ 28.5万 - 项目类别:
相似海外基金
T32 Urologic Oncology Research Training Program
T32 泌尿肿瘤学研究培训计划
- 批准号:
10024657 - 财政年份:1999
- 资助金额:
$ 28.5万 - 项目类别:
T32 Urologic Oncology Research Training Program
T32 泌尿肿瘤学研究培训计划
- 批准号:
10474284 - 财政年份:1999
- 资助金额:
$ 28.5万 - 项目类别:














{{item.name}}会员




